Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) Beta : N/A (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-05), Intelligent Medicine Acquisition's Beta is Not available.

Intelligent Medicine Acquisition Beta Historical Data

The historical data trend for Intelligent Medicine Acquisition's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition Beta Chart

Intelligent Medicine Acquisition Annual Data

Trend

Dec21

Dec22

Beta

Intelligent Medicine Acquisition Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22
Beta	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Intelligent Medicine Acquisition's Beta

For the Shell Companies subindustry, Intelligent Medicine Acquisition's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intelligent Medicine Acquisition's Beta Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Intelligent Medicine Acquisition's Beta distribution charts can be found below:

* The bar in red indicates where Intelligent Medicine Acquisition's Beta falls into.

Intelligent Medicine Acquisition Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Intelligent Medicine Acquisition (NAS:IQMDU) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Intelligent Medicine Acquisition Beta Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Beta

Comparable Companies

Traded in Other Exchanges

N/A

Address

9001 Burdette Road, Bethesda, MD, USA, 20817

Website

https://iqmdspac.com

Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

Executives

Goldman Sachs & Co. Llc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken	director	2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary	director	3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon	director, officer: CEO and CFO	9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball	director	9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc	10 percent owner	9001 BURDETTE ROAD, BETHESDA MD 20817

Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) Headlines

From GuruFocus

Intelligent Medicine Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 27, 2021

By Business Wire Business Wire • 12-23-2021

Intelligent Medicine Acquisition Corp. Announces Closing of Upsized $207,000,000 Initial Public Offering

By Business Wire Business Wire • 11-10-2021

Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares

By Business Wire Business Wire • 04-26-2023

Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders

By Business Wire Business Wire • 02-03-2023